ATE449607T1 - Arsentherapie zur behandlung von autoimmunerkrankungen - Google Patents

Arsentherapie zur behandlung von autoimmunerkrankungen

Info

Publication number
ATE449607T1
ATE449607T1 AT03740670T AT03740670T ATE449607T1 AT E449607 T1 ATE449607 T1 AT E449607T1 AT 03740670 T AT03740670 T AT 03740670T AT 03740670 T AT03740670 T AT 03740670T AT E449607 T1 ATE449607 T1 AT E449607T1
Authority
AT
Austria
Prior art keywords
autoimmune diseases
treatment
arsenic
therapy
arsenic therapy
Prior art date
Application number
AT03740670T
Other languages
English (en)
Inventor
Alix Kmar Chelbi
Pedro Bobe
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE449607T1 publication Critical patent/ATE449607T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/36Arsenic; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03740670T 2002-04-26 2003-04-25 Arsentherapie zur behandlung von autoimmunerkrankungen ATE449607T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0205276A FR2838965B1 (fr) 2002-04-26 2002-04-26 Therapie par l'arsenic du syndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme
PCT/FR2003/001314 WO2003090766A1 (fr) 2002-04-26 2003-04-25 Therapie par l'arsenic du styndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme

Publications (1)

Publication Number Publication Date
ATE449607T1 true ATE449607T1 (de) 2009-12-15

Family

ID=28799974

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03740670T ATE449607T1 (de) 2002-04-26 2003-04-25 Arsentherapie zur behandlung von autoimmunerkrankungen

Country Status (9)

Country Link
US (2) US20050163863A1 (de)
EP (1) EP1499330B1 (de)
AT (1) ATE449607T1 (de)
AU (1) AU2003262832A1 (de)
CA (1) CA2483764C (de)
DE (1) DE60330233D1 (de)
ES (1) ES2337568T3 (de)
FR (1) FR2838965B1 (de)
WO (1) WO2003090766A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8394422B2 (en) * 2002-04-26 2013-03-12 Centre National De La Recherche Scientifique (Cnrs) Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans
US20060292243A1 (en) * 2005-06-24 2006-12-28 Shao-Chi Hsin Arsenic compounds for the treatment of the arsenic-sensitive blast-cell related diseases
US8945505B2 (en) * 2007-02-02 2015-02-03 Panaphix, Inc. Use of arsenic compounds for treatment of pain and inflammation
FR3004949B1 (fr) 2013-04-26 2016-02-05 Centre Nat Rech Scient Traitement de maladies autoimmunes et inflammatoires par les composes de l'arsenic as203 et/ou as205 administres par voie locale
US10716807B2 (en) * 2017-05-09 2020-07-21 Medsenic Method of treating relapsing-remitting multiple sclerosis using arsenic trioxide

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2539993A1 (fr) 1983-01-28 1984-08-03 Darcheux Mario Baume agissant sur les plaies cancereuses
FR2572730B1 (fr) 1984-11-02 1987-12-11 Centre Nat Rech Scient Nouveaux derives de l'arsenic, leur preparation et leur application, notamment comme medicaments antiparasitaires
IT1280014B1 (it) 1993-03-17 1997-12-23 Walter Tarello Farmaci attivi contro l'agente eziologico della sindrome da astenia cronica
ITTO930510A1 (it) 1993-07-09 1993-10-07 Walter Tarello Farmaci attivi contro la chronic fatigue syndrome (c.f.s.)
US5889048A (en) 1994-02-18 1999-03-30 Vorobieva; Tamara Vasilievna Methods and compositions for treating defective cell functions
US5550153A (en) 1994-11-14 1996-08-27 Kerz; Phillip D. Method for treating heartworm-infected canines
CN1175451A (zh) * 1997-07-20 1998-03-11 迟经惠 红斑狼疮膏
WO2000009140A1 (en) 1997-07-24 2000-02-24 Thomas Jefferson University Composition and method of using tumor cells
DK1391206T3 (da) 1997-10-15 2008-09-01 Polarx Biopharmaceuticals Inc Farmaceutiske præparater der omfatter arsentrioxyd til behandling af ikke-Hodgkins lymfom
CA2309652C (en) 1997-11-10 2013-01-29 Memorial Sloan-Kettering Cancer Center Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
CN1233476A (zh) 1998-04-24 1999-11-03 陆道培 治疗急性白血病的药物及其制备方法
KR100272835B1 (ko) 1998-05-08 2000-11-15 배일주 천연 화학물질 육산화사비소의 신규한 항종양 치료제로서의 용도 및 그 약학적 조성물
FR2781674B1 (fr) * 1998-07-31 2002-06-28 Inst Nat Sante Rech Med Utilisation de nouveaux agents inducteurs de mort cellulaire en synergie avec les interferons
FR2782010A1 (fr) 1998-08-06 2000-02-11 Inst Vaisseaux Et Du Sang Nouvelle utilisation d'un compose d'arsenic vis-a-vis de la leucemie megacaryocytaire ou plaquettaire
US6191123B1 (en) 1999-03-19 2001-02-20 Parker Hughes Institute Organic-arsenic compounds
TW200408407A (en) * 2001-11-30 2004-06-01 Dana Farber Cancer Inst Inc Methods and compositions for modulating the immune system and uses thereof
US8394422B2 (en) * 2002-04-26 2013-03-12 Centre National De La Recherche Scientifique (Cnrs) Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans

Also Published As

Publication number Publication date
FR2838965A1 (fr) 2003-10-31
FR2838965B1 (fr) 2004-06-25
WO2003090766A1 (fr) 2003-11-06
US8497300B2 (en) 2013-07-30
EP1499330A1 (de) 2005-01-26
AU2003262832A1 (en) 2003-11-10
US20050163863A1 (en) 2005-07-28
ES2337568T3 (es) 2010-04-27
DE60330233D1 (de) 2010-01-07
CA2483764C (fr) 2011-03-08
CA2483764A1 (fr) 2003-11-06
EP1499330B1 (de) 2009-11-25
US20090098216A1 (en) 2009-04-16

Similar Documents

Publication Publication Date Title
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
CY1109229T1 (el) Χρηση σπογγοσινης (2-μεθοξυαδενοσινης) για τη θεραπεια πονου, συγκεκριμενα υπερευαισθησιας στο πονο
EA200601212A1 (ru) Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение
EA200201247A1 (ru) Соединения для лечения болезни альцгеймера
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
AU5584901A (en) Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
TNSN07208A1 (en) 3,5-DISUBTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d] PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF
MY127290A (en) New use of flibanserin
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
DE502004006619D1 (de) Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
ATE254461T1 (de) Behandlung von augenschmerzen
ATE412646T1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
GB0130677D0 (en) Medicaments and novel compounds
ATE357912T1 (de) Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten
BRPI0417105A (pt) métodos de tratamento de doenças autoimunológicas em pacientes
ATE432936T1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
ATE449607T1 (de) Arsentherapie zur behandlung von autoimmunerkrankungen
ATE542542T1 (de) Verwendung von gp130 aktivatoren zur behandlung von diabetischer neuropathie
ATE453386T1 (de) Polyamin-verbindungen zur behandlung von chemokin-rezeptor-vermittelten krankheiten
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
EA200600115A1 (ru) Производные 2-аминобензойной кислоты
ATE423780T1 (de) Makrozyclen zur behandlung von krebserkrankungen
SE0100873D0 (sv) Method of treatment

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties